Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Johnson & Johnson Falls Premarket; Moderna and Altimeter Rise

Stock MarketsApr 13, 2021 08:20AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Tuesday, April 13th. Please refresh for updates.

  • Johnson & Johnson (NYSE:JNJ) stock fell 2.3% after U.S. medical authorities called for a pause in the use of the drugmaker’s Covid-19 vaccine over blood clotting issues.

  • Altimeter Growth Corp (NASDAQ:AGC) stock rose 5.1% with the SPAC set to take Singapore-based Grab Holdings public in the U.S. The deal has been valued at almost $40 billion, the largest ever deal involving a SPAC.

  • Moderna (NASDAQ:MRNA) stock rose 7.7%, benefiting from J&J’s woes, which give it a chance to grab share in the key U.S. market. The drugmaker’s Covid-19 vaccine was rolled out for use in England earlier Tuesday. 

  • FedEx (NYSE:FDX) stock rose 1% after the investment bank KeyBanc Capital Markets upgraded its stance on the delivery giant to ‘overweight’ from ‘sector weight’, saying it can still grow numbers even as the market reopens. 

  • Alibaba (NYSE:BABA) ADR fell 0.9% after regulators in China ordered the e-commerce giant’s financial technology affiliate Ant Group to revamp its business.

  • American Airlines (NASDAQ:AAL) stock fell 3.4%, United Airlines (NASDAQ:UAL) stock dropped 3.1%, Royal Caribbean (NYSE:RCL) stock fell 2.9% and Carnival (NYSE:CUK) stock fell 2.8% as the J&J vaccine news hits stocks associated with the reopening, including the airlines and cruise companies.

  • Bristol-Myers Squibb (NYSE:BMY) stock rose 0.7% after Truist Securities upgraded its stance on the pharmaceutical company to ‘buy’ from ‘hold’, citing the company’s strong drug pipeline.

  • Credit Suisse (SIX:CSGN) stock fell 0.9% with the Swiss banking giant likely to see changes to its board. Proxy adviser Glass Lewis urged the bank’s shareholders to oppose Andreas Gottschling's re-election, on grounds that as risk committee chairman he should be held accountable for losses generated by its dealings with Greensill Bank and Archegos Capital Management.
Johnson & Johnson Falls Premarket; Moderna and Altimeter Rise
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (8)
Dave Jones
Dave Jones Apr 13, 2021 1:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
do something about the spam in the comments you useless bastards. did that get your attention?
Ronald Warren
Ronald Warren Apr 13, 2021 1:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hey Dave! They certainly have no problem censoring me when I have a touchy subject to discuss.
Dave Jones
Dave Jones Apr 13, 2021 1:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
spam
Bobster Bambino
Bobster Bambino Apr 13, 2021 9:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
First talcum powder. Now this. Keep advertising your a caring company lol
Kenneth nelson
grasshopper Apr 13, 2021 9:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I go the J and J shot 3 weeks ago and I have been sick ever since
CHAD TENDIES
CHAD TENDIES Apr 13, 2021 8:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RIP anyone who trusted the warp speed blood clotting vaccine for a mild coronavirus with a 99% survival rate
sachin nerurkar
sachin nerurkar Apr 13, 2021 8:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Please do mention the percentage of people getting blood clot after taking J&J vaccine.
Roger Miller
Roger Miller Apr 13, 2021 8:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sachin nerurkar To be fair, they rarely mention the survival rate of healthy people who get covid.
Deanna Reiniger
Deanna Reiniger Apr 13, 2021 8:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sachin nerurkar  they did in a separate article
Mukaila Olatide
Mukaila Olatide Apr 13, 2021 8:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I love it when a plan to correct the markets is in play now... Lol
Patti R Callanhan
Patti R Callanhan Apr 13, 2021 8:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lol whats your name....how long have you been trading.
Franco Dominguez
Franco Dominguez Apr 13, 2021 8:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
J&J returns our moneys
Vincent Li
Vincent Li Apr 13, 2021 8:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I love it when a plan to correct the markets is in play now... Lol
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email